Ohio cancer center breaks ground on $1 billion addition

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 19 No 8
Volume 19
Issue 8

The Ohio State University Comprehensive Cancer Center–Authur G. James Cancer Hospital and Richard J. Solove Research Institution (OSUCCC-James) has begun construction on a 276-bed cancer facility.

The Ohio State University Comprehensive Cancer Center-Authur G. James Cancer Hospital and Richard J. Solove Research Institution (OSUCCC-James) has begun construction on a 276-bed cancer facility.

Entitled ProjectONE, the Columbus-based facility will allow the center to keep up with a projected 21% growth in admission during the next decade, according to cancer center administrators. The new hospital will serve as a research center,with 10,000 full-time jobs generated. Visit projectone.osu.edu/ for more information.

Based on community feedback, OSU Medical Center CEO Steven Gabbe, MD, announced revisions to the original ProjectONE design in June 2010.

"As with building a house, the best plans often need refining as planning and construction progress," Dr. Gabbe said. "The new model calls for four neighborhoods, each with its own tower. The neighborhoods include three areas with 12-bed patient units and a fourth for education and clinical research. Rooftop gardens accessible to patients and their families have been added as well."

OSUCC-James is slated to open a 103,000-square foot Women's Breast Center in January 2011.

In addition, the James Cancer Hospital will add several dozen new beds to accommodate new surgical, breast cancer, leukemia, and lymphoma patients.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
2 experts in this video
2 experts in this video
Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.
Increasing the use of patient-reported outcomes may ensure that practitioners can fully ascertain the impact of treatment for rare lymphomas.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Related Content